US 10435677
Genetically modified human cell with a corrected mutant sickle cell mutation
granted A61KA61K35/28A61K40/10
Quick answer
US patent 10435677 (Genetically modified human cell with a corrected mutant sickle cell mutation) held by Sangamo Therapeutics, Inc. expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/28, A61K40/10, A61K40/40, A61K48/005